Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Verhoeven

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Joint Bone Spine|July 19, 2024
Interest in various treatments for osteoarthritis among the French population: A Google Trends analysisOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|November 1, 2020
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumaticaNicolas Giraud, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|May 24, 2017
IL-23/Th17 targeted therapies in SAPHO syndrome. A case seriesDaniel Wendling, François Aubin, Frank Verhoeven, et al.
Joint Bone Spine|March 15, 2022
On the use of <sup>18</sup>F FDG PET-CT in spondyloarthritis. Comment on: "Use of <sup>18</sup>F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Pean de Ponfilly-Sotier M, et al. Joint Bone Spine. 2021;89:105325Nicolas Giraud, Frank Verhoeven, Daniel Wendling, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 20, 2026
A painful bipartite patellaOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Expert Opinion on Drug Safety|October 15, 2016
Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?Daniel Wendling, Frank Verhoeven, Xavier Guillot, et al.
Joint Bone Spine|March 24, 2023
Psoriatic dactylitisDaniel Wendling, Frank Verhoeven, Mickael Chouk, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 7, 2021
Daniel Wendling, Frank Verhoeven, Mickael Chouk, et al.
Joint Bone Spine|April 6, 2024
Can we consider a pre-clinical state of axial spondyloarthritis?Daniel Wendling, Philippe Goupille, Frank Verhoeven, et al.
Annals of the Rheumatic Diseases|March 25, 2025
Correspondence on 'The Assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis' by Poddubnyy D, et alDaniel Wendling, Olivier Fakih, Frank Verhoeven, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Joint Bone Spine|July 19, 2024
Interest in various treatments for osteoarthritis among the French population: A Google Trends analysisOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|November 1, 2020
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumaticaNicolas Giraud, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|May 24, 2017
IL-23/Th17 targeted therapies in SAPHO syndrome. A case seriesDaniel Wendling, François Aubin, Frank Verhoeven, et al.
Joint Bone Spine|March 15, 2022
On the use of <sup>18</sup>F FDG PET-CT in spondyloarthritis. Comment on: "Use of <sup>18</sup>F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Pean de Ponfilly-Sotier M, et al. Joint Bone Spine. 2021;89:105325Nicolas Giraud, Frank Verhoeven, Daniel Wendling, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 20, 2026
A painful bipartite patellaOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Expert Opinion on Drug Safety|October 15, 2016
Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?Daniel Wendling, Frank Verhoeven, Xavier Guillot, et al.
Joint Bone Spine|March 24, 2023
Psoriatic dactylitisDaniel Wendling, Frank Verhoeven, Mickael Chouk, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 7, 2021
Daniel Wendling, Frank Verhoeven, Mickael Chouk, et al.
Joint Bone Spine|April 6, 2024
Can we consider a pre-clinical state of axial spondyloarthritis?Daniel Wendling, Philippe Goupille, Frank Verhoeven, et al.
Annals of the Rheumatic Diseases|March 25, 2025
Correspondence on 'The Assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis' by Poddubnyy D, et alDaniel Wendling, Olivier Fakih, Frank Verhoeven, et al.
Pageof 15